Undisclosed antibody-drug conjugate (AbbVie/Seattle Genetics)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameUndisclosed antibody-drug conjugate (AbbVie/Seattle Genetics)

Drug Alias NameUndisclosed ADC

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsHematologic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAbbvie Inc Seagen Inc

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsHematologic Neoplasms

ATC CodeN/A